Sponsor Deadline
Posted: 12/4/2023

Research Innovation Award

The BCAN Bladder Cancer Research Innovation Awards support exceptionally novel, high-risk, high-reward projects with great potential to produce breakthroughs in our understanding of bladder cancer. The proposed research may be basic, translational, clinical or epidemiological and must have direct applicability and relevance to bladder cancer and/or upper tract urothelial carcinoma. Applications must include innovative approaches and new ideas (e.g., novel theoretical concepts, methodologies, instrumentation, interventions, etc.) to be eligible for funding. Projects must address an important problem and/or critical barrier to progress as well as a significant knowledge gap in the field of bladder cancer research.

Interested applicants must submit a Letter of Intent by Jan 12, 2024.

Eligibility Requirements
  • Full time, independent investigators affiliated with a non-profit academic, medical or research institution within the United States or Canada.
  • Applicant must have a medical and/or doctoral degree (including Ph.D., M.D., D.O., D.D.S, D.V.M, Pharm.D., Sc.D., D.N.S. or equivalent doctoral degree) at the time of submission. If the applicant’s primary area of expertise is outside of bladder cancer, including a Co-Primary Investigator with expertise in bladder cancer research is acceptable and recommended.
  • Applicant may not have previously received a BCAN Research Innovation Award nor have other funding with significant scientific overlap.
  • Applicants may hold only one active grant from BCAN at a time and may not apply for this award and for any other BCAN research award concurrently.
Amount Description

Project Period: 2 years

Total Funding: Not to exceed $300,000 including direct and indirect costs.